Aura Biosciences, Inc. ( AURA) - Stock Earnings
AURA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
AURA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -25.6 million USD | — USD |
| 2026Q1 | -33.7 million USD | — USD |
| 2026Q2 | -45.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AURA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -76.4 million USD | — USD |
| 2024 | -86.9 million USD | — USD |
| 2025 | -106.2 million USD | — USD |
| 2026 Est. | — | — |
AURA
Price: $6.28
52 week price:
Earnings Per Share: -1.73 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 120900
Market Capitalization: 661.0 million